EFFICACY OF UPADACITINIB AS AN INDUCTION THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS, WITH OR WITHOUT PREVIOUS TREATMENT FAILURE OF BIOLOGIC THERAPY: DATA FROM THE DOSE-RANGING PHASE 2B STUDY U-ACHIEVE

Remo Panaccione  1     Geert R. D'Haens  2     William Sandborn  3     Subrata Ghosh  4     Stefan Schreiber  5     Satoshi Tanida  6     Wen Zhou  7     Fabio Cataldi     David Pugatch     Bidan Huang     Wangang Xie     Peter Higgins    
1 University of Calgary,Calgary,Canada
2 Academic Medical Center,Amsterdam,Netherlands
3 University of California,San Diego,United States
4 Institute Of Translational Medicine,Birmingham,United Kingdom
5 Universit├Ąt Kiel UKSH Medizinische Abt. I - UKSH,Kiel,Germany
6 Nagoya City University Graduate School of Medical Sciences,Nagoya,Japan
7 A

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing